As clinical trials become more complex, traditional monitoring models are increasingly difficult to sustain. Rigid structures, frequent handoffs, and limited site continuity can slow issue resolution and introduce unnecessary risk. These challenges were explored in the webinar Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success, featuring clinical operations leaders from inSeption Group and Veralox Therapeutics.
The discussion focused on how flexible, site-centric monitoring approaches are helping sponsors and CROs improve communication, maintain compliance, and strengthen trial execution. Speakers shared real-world examples demonstrating how embedded oversight roles and adaptive resourcing models provide greater consistency at the site level, enabling faster problem-solving and stronger working relationships.
Designed for both large global studies and specialized rare disease trials, this session highlights how a people-first monitoring strategy—supported by experienced clinical operations teams—can enhance trial performance while protecting timelines, quality, and regulatory alignment.
Watch the webinar to learn how modern monitoring models are supporting lasting clinical trial success.
